| James B Stewart, OD | |
|
5091 W Bethel Ave, Muncie, IN 47304-8511 | |
| (317) 841-2020 | |
| (317) 570-7433 |
| Full Name | James B Stewart |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 39 Years |
| Location | 5091 W Bethel Ave, Muncie, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194702639 | NPI | - | NPPES |
| 100094430 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 18002206A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Surgeons Of Indiana, Pc | 0446267876 | 18 |
| American Health Network Of Indiana Llc | 9830093533 | 212 |
News Archive
A study, which was published in the journal New Microbes and New Infections, focused on the possible reasons for SARS-CoV-2 reinfection.
The Hill: Doctors who belong to the American Society of Interventional Pain Physicians want lawmakers to give money to help states begin collecting and sharing data on patients who "doctor shop" for pain medications. The group wants $55 million for the program and are asking Congress "to reauthorize a 2005 bill providing grants to states that collect prescription drug information and share it with physicians and pharmacists — and law enforcement officials when there's an investigation — while protecting patients' privacy.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced topline results from a Phase II clinical trial conducted by Roche and Genentech, Curis' collaborator and a wholly owned member of the Roche Group, of GDC-0449, a first-in-class Hedgehog pathway inhibitor. GDC-0449 was tested in combination with Avastin® (bevacizumab) and FOLFOX or FOLFIRI chemotherapy in first-line metastatic colorectal cancer patients.
Breast cancer metastasis, the process by which cancer spreads, may be prevented through the new use of a class of drugs already approved by the U.S. Food and Drug Administration.
In a major advance in the field of neuropsychiatry, researchers in the Vollum Institute at Oregon Health & Science University have illuminated how cocaine and amphetamines disrupt the normal functioning of the dopamine transporter in the brain.
› Verified 1 days ago
| Provider Name | American Health Network Of Indiana Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1831236272 PECOS PAC ID: 9830093533 Enrollment ID: O20031124000691 |
News Archive
A study, which was published in the journal New Microbes and New Infections, focused on the possible reasons for SARS-CoV-2 reinfection.
The Hill: Doctors who belong to the American Society of Interventional Pain Physicians want lawmakers to give money to help states begin collecting and sharing data on patients who "doctor shop" for pain medications. The group wants $55 million for the program and are asking Congress "to reauthorize a 2005 bill providing grants to states that collect prescription drug information and share it with physicians and pharmacists — and law enforcement officials when there's an investigation — while protecting patients' privacy.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced topline results from a Phase II clinical trial conducted by Roche and Genentech, Curis' collaborator and a wholly owned member of the Roche Group, of GDC-0449, a first-in-class Hedgehog pathway inhibitor. GDC-0449 was tested in combination with Avastin® (bevacizumab) and FOLFOX or FOLFIRI chemotherapy in first-line metastatic colorectal cancer patients.
Breast cancer metastasis, the process by which cancer spreads, may be prevented through the new use of a class of drugs already approved by the U.S. Food and Drug Administration.
In a major advance in the field of neuropsychiatry, researchers in the Vollum Institute at Oregon Health & Science University have illuminated how cocaine and amphetamines disrupt the normal functioning of the dopamine transporter in the brain.
› Verified 1 days ago
| Provider Name | Eye Surgeons Of Indiana, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457399834 PECOS PAC ID: 0446267876 Enrollment ID: O20060309000629 |
News Archive
A study, which was published in the journal New Microbes and New Infections, focused on the possible reasons for SARS-CoV-2 reinfection.
The Hill: Doctors who belong to the American Society of Interventional Pain Physicians want lawmakers to give money to help states begin collecting and sharing data on patients who "doctor shop" for pain medications. The group wants $55 million for the program and are asking Congress "to reauthorize a 2005 bill providing grants to states that collect prescription drug information and share it with physicians and pharmacists — and law enforcement officials when there's an investigation — while protecting patients' privacy.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced topline results from a Phase II clinical trial conducted by Roche and Genentech, Curis' collaborator and a wholly owned member of the Roche Group, of GDC-0449, a first-in-class Hedgehog pathway inhibitor. GDC-0449 was tested in combination with Avastin® (bevacizumab) and FOLFOX or FOLFIRI chemotherapy in first-line metastatic colorectal cancer patients.
Breast cancer metastasis, the process by which cancer spreads, may be prevented through the new use of a class of drugs already approved by the U.S. Food and Drug Administration.
In a major advance in the field of neuropsychiatry, researchers in the Vollum Institute at Oregon Health & Science University have illuminated how cocaine and amphetamines disrupt the normal functioning of the dopamine transporter in the brain.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James B Stewart, OD 9202 N Meridian St, Indianapolis, IN 46260-1800 Ph: (317) 841-2020 | James B Stewart, OD 5091 W Bethel Ave, Muncie, IN 47304-8511 Ph: (317) 841-2020 |
News Archive
A study, which was published in the journal New Microbes and New Infections, focused on the possible reasons for SARS-CoV-2 reinfection.
The Hill: Doctors who belong to the American Society of Interventional Pain Physicians want lawmakers to give money to help states begin collecting and sharing data on patients who "doctor shop" for pain medications. The group wants $55 million for the program and are asking Congress "to reauthorize a 2005 bill providing grants to states that collect prescription drug information and share it with physicians and pharmacists — and law enforcement officials when there's an investigation — while protecting patients' privacy.
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced topline results from a Phase II clinical trial conducted by Roche and Genentech, Curis' collaborator and a wholly owned member of the Roche Group, of GDC-0449, a first-in-class Hedgehog pathway inhibitor. GDC-0449 was tested in combination with Avastin® (bevacizumab) and FOLFOX or FOLFIRI chemotherapy in first-line metastatic colorectal cancer patients.
Breast cancer metastasis, the process by which cancer spreads, may be prevented through the new use of a class of drugs already approved by the U.S. Food and Drug Administration.
In a major advance in the field of neuropsychiatry, researchers in the Vollum Institute at Oregon Health & Science University have illuminated how cocaine and amphetamines disrupt the normal functioning of the dopamine transporter in the brain.
› Verified 1 days ago
Morrison Eye Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3631 N Morrison Rd, Muncie, IN 47304 Phone: 765-286-8888 Fax: 765-747-7962 | |
Matthew L Harkin, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2304 N Wheeling Ave, Muncie, IN 47303 Phone: 765-288-5301 Fax: 765-284-3460 | |
Dr. Kenneth Robert Crawley, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3501 N Granville Ave Ste L4, Muncie Mall, Muncie, IN 47303 Phone: 765-286-5977 Fax: 765-286-5988 | |
Burlington Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 3303 E Memorial Dr, Muncie, IN 47302 Phone: 765-282-2020 Fax: 765-284-1150 | |
Dr. Jason Matthew Storms, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4801 W Clara Ln, Muncie, IN 47304 Phone: 765-284-8460 | |
Kregg Koons O.d., Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 3300 Purdue Ave., Muncie, IN 47304 Phone: 765-288-1935 |